[Placental insufficiency].
D011464:Epoprostenol / Q000627:therapeutic use; D005260:Female; D005313:Fetal Death / Q000209:etiology; D005317:Fetal Growth Retardation / Q000209:etiology; D006728:Hormones / Q000097:blood; D006801:Humans; D007231:Infant, Newborn; D008991:Monitoring, Physiologic; D010920:Placenta / Q000201:enzymology / Q000473:pathology; D010922:Placenta Diseases / Q000175:diagnosis / Q000209:etiology / Q000473:pathology / Q000628:therapy; D010927:Placental Insufficiency / Q000175:diagnosis / Q000209:etiology / Q000473:pathology / Q000628:therapy; D010974:Platelet Aggregation; D011225:Pre-Eclampsia / Q000150:complications; D011247:Pregnancy; D011257:Pregnancy Proteins / Q000032:analysis; D011254:Pregnancy in Diabetics / Q000150:complications
D006728:Hormones; D011257:Pregnancy Proteins; D011464:Epoprostenol
La insuficiencia placentaria.